Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ali Ataya

Pulmonary Vascular Med · UF

View

Dr. Naftali Kaminski

Interstitial Lung Disease · Yale College

View

Dr. Auston Stiefer

Interstitial Lung Disease · CU Anschutz Medical Campus

View

Dr. Justin Zhang

Critical Care · UCLA

View

Dr. Panagis Galiatsatos

Critical Care · Johns Hopkins

View

Dr. MeiLan Han

Asthma & COPD · UMHS

View

Dr. Kevin Chung

Critical Care · SeaStar Medical

View

Dr. Diego J. Maselli

Asthma & COPD · UTHSCSA

View

Dr. Amos E. Dodi

Critical Care · MMC

View

Dr. Imre Noth

Interstitial Lung Disease · University of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.

    Dec 3, 2025DOI: 10.1161/circheartfailure.125.013591Journal ArticleAHA

    Written by: Yogesh N V ReddyRobert P FrantzAnna R HemnesPaul M HassounEvelyn M HornJane A LeopoldFranz RischardErika B RosenzweigNicholas S HillSerpil C ErzurumGerald J BeckJ Emanuel FinetChristine L JellisStephen C MathaiW H Wilson TangBarry A BorlaugPVDOMICS Study Group

    Find these authors on Roon

    YR

    Dr. Yogesh Reddy

    Advanced Heart Failure · Mayo Clinic College of Medicine

    AH

    Dr. Anna Hemnes

    Pulmonary Vascular Med · Vanderbilt

    Summary

    BACKGROUND: Although obesity and insulin resistance (IR) are established risk factors for left heart dysfunction, their clinical impact in group 1 pulmonary hypertension (PH) remains unclear. We sought to determine the impact of excess adiposity versus IR on biventricular hemodynamic and functional reserve in group 1 PH.METHODS: Homeostasis model of insulin resistance and adiposity indices (body mass index [BMI], fat mass, waist circumference) were measured among group 1 patients with PH recruited to PVDOMICS (Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics). Functional capacity, and dynamic pulmonary capillary wedge pressure (PCWP) and right atrial pressure responses were compared stratified by obesity (BMI≥30 kg/m2) and IR status (HOMA-IR≥2.6) using repeated-measure mixed models.RESULTS: Among patients with group 1 PH (n=418), 158 (38%) had BMI≥30 kg/m2 (94 [60%] of whom had IR), and 260 (62%) had BMI<30 kg/m2 (74 [28%] of whom had IR). Among those with waist circumference measurement (n=375), 287 (77%) had excess adiposity by elevated waist/height ratio, with 214 (57%) having elevated waist circumference. Patients with obesity had worse quality of life, exercise capacity and left heart remodeling, along with higher resting/dynamic PCWP, right atrial pressure and cardiac output (P<0.0001 for all). Higher PCWP response with obesity persisted after adjusting for IR (IR-adjusted PCWP+2.5 mm Hg [95% CI, +1.4 to +3.6]; P<0.0001). All adiposity indices were consistently associated with PCWP response, but IR was not. Similar associations were observed between adiposity indices with higher right atrial pressure and cardiac output. Greater visceral adiposity as measured by body shape index (hazard ratio, 2.01 [95% CI, 1.16-3.47]; P=0.01) or weight-adjusted waist index (hazard ratio, 1.64 [95% CI, 1.10-2.46]; P=0.01) was associated with worse survival.CONCLUSIONS: Excess adiposity is common in group 1 PH, occurring in 4 out of 5 patients by the more sensitive waist/height ratio, in contrast to only 2 out of 5 patients having obesity by traditional BMI criteria. Excess adiposity is associated with higher biventricular filling pressures, cardiac output demand, worse functional status and reduced survival. These data support trials of adipose-reducing therapies in patients with group 1 PH and excess adiposity.
    AHDr. Anna Hemnes

    Dr. Anna Hemnes

    Pulmonology & Critical Care · Pulmonary Vascular Medicine
    Vanderbilt Health
    annahemnes